- Home
- RXO vs INDV Comparison
RXO vs INDV Comparison
Compare RXO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RXO | INDV |
|---|---|---|
| Founded | 2022 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RXO | INDV |
|---|---|---|
| Price | $19.73 | $34.94 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $16.33 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 05-07-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 72.81 | ★ 8100.00 |
| EPS | N/A | ★ 1.67 |
| Revenue | ★ $5,742,000,000.00 | $1,239,000,000.00 |
| Revenue This Year | $0.49 | N/A |
| Revenue Next Year | $6.90 | N/A |
| P/E Ratio | ★ N/A | $20.69 |
| Revenue Growth | ★ 26.20 | 4.29 |
| 52 Week Low | $10.43 | $22.22 |
| 52 Week High | $29.90 | $42.81 |
Technical Indicators
Market Signals| Indicator | RXO | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 31.82 |
| Support Level | $19.39 | $32.42 |
| Resistance Level | $20.19 | $35.75 |
| Average True Range (ATR) | 1.09 | 1.10 |
| MACD | -0.09 | -0.28 |
| Stochastic Oscillator | 0.36 | 10.76 |
Price Performance
Historical ComparisonAbout RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).